Abbott Laboratories (ABT) Inventory Average (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Inventory Average data on file, last reported at $6.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 5.02% year-over-year to $6.7 billion; the trailing twelve-month figure through Mar 2026 stood at $6.7 billion (up 5.02% YoY), and the FY2025 full-year result was $6.3 billion, down 0.64% from the prior year.
• Inventory Average advanced to $6.7 billion in Q1 2026, from $6.6 billion in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $6.8 billion in Q3 2025 to a low of $5.4 billion in Q1 2022.
• A 5-year average of $6.5 billion and a median of $6.6 billion in 2023 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average advanced 18.42% in 2023 and declined 4.21% in 2025, its largest moves.
• Tracing ABT's Inventory Average over 5 years: stood at $6.0 billion in 2022, then climbed by 11.03% to $6.6 billion in 2023, then dropped by 1.61% to $6.5 billion in 2024, then climbed by 1.45% to $6.6 billion in 2025, then climbed by 2.13% to $6.7 billion in 2026.
• Business Quant data shows ABT's Inventory Average at $6.7 billion in Q1 2026, $6.6 billion in Q4 2025, and $6.8 billion in Q3 2025.